Literature DB >> 24534704

Impact of myeloperoxidase-LDL interactions on enzyme activity and subsequent posttranslational oxidative modifications of apoB-100.

Cédric Delporte1, Karim Zouaoui Boudjeltia, Caroline Noyon, Paul G Furtmüller, Vincent Nuyens, Marie-Christine Slomianny, Philippe Madhoun, Jean-Marc Desmet, Pierre Raynal, Damien Dufour, Chintan N Koyani, Florence Reyé, Alexandre Rousseau, Michel Vanhaeverbeek, Jean Ducobu, Jean-Claude Michalski, Jean Nève, Luc Vanhamme, Christian Obinger, Ernst Malle, Pierre Van Antwerpen.   

Abstract

Oxidation of LDL by the myeloperoxidase (MPO)-H2O2-chloride system is a key event in the development of atherosclerosis. The present study aimed at investigating the interaction of MPO with native and modified LDL and at revealing posttranslational modifications on apoB-100 (the unique apolipoprotein of LDL) in vitro and in vivo. Using amperometry, we demonstrate that MPO activity increases up to 90% when it is adsorbed at the surface of LDL. This phenomenon is apparently reflected by local structural changes in MPO observed by circular dichroism. Using MS, we further analyzed in vitro modifications of apoB-100 by hypochlorous acid (HOCl) generated by the MPO-H2O2-chloride system or added as a reagent. A total of 97 peptides containing modified residues could be identified. Furthermore, differences were observed between LDL oxidized by reagent HOCl or HOCl generated by the MPO-H2O2-chloride system. Finally, LDL was isolated from patients with high cardiovascular risk to confirm that our in vitro findings are also relevant in vivo. We show that several HOCl-mediated modifications of apoB-100 identified in vitro were also present on LDL isolated from patients who have increased levels of plasma MPO and MPO-modified LDL. In conclusion, these data emphasize the specificity of MPO to oxidize LDL.

Entities:  

Keywords:  3-chlorotyrosine; apolipoprotein B-100; epitope mapping; hypochlorous acid; inflammation; low density lipoprotein; myeloperoxidase activity

Mesh:

Substances:

Year:  2014        PMID: 24534704      PMCID: PMC3966708          DOI: 10.1194/jlr.M047449

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  53 in total

1.  Myeloperoxidase binds to low-density lipoprotein: potential implications for atherosclerosis.

Authors:  A C Carr; M C Myzak; R Stocker; M R McCall; B Frei
Journal:  FEBS Lett       Date:  2000-12-29       Impact factor: 4.124

2.  Structure of apolipoprotein B-100 of human low density lipoproteins.

Authors:  C Y Yang; Z W Gu; S A Weng; T W Kim; S H Chen; H J Pownall; P M Sharp; S W Liu; W H Li; A M Gotto
Journal:  Arteriosclerosis       Date:  1989 Jan-Feb

3.  Selective oxidation in vitro by myeloperoxidase of the N-terminal amine in apolipoprotein B-100.

Authors:  C Yang; J Wang; A N Krutchinsky; B T Chait; J D Morrisett; C V Smith
Journal:  J Lipid Res       Date:  2001-11       Impact factor: 5.922

4.  Revealing binding sites for myeloperoxidase on the surface of human low density lipoproteins.

Authors:  Alexej V Sokolov; Andrej V Chekanov; Valeria A Kostevich; Denis V Aksenov; Vadim B Vasilyev; Oleg M Panasenko
Journal:  Chem Phys Lipids       Date:  2010-11-03       Impact factor: 3.329

5.  3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima.

Authors:  S L Hazen; J W Heinecke
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

6.  Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins.

Authors:  E Malle; G Waeg; R Schreiber; E F Gröne; W Sattler; H J Gröne
Journal:  Eur J Biochem       Date:  2000-07

7.  Triggering of inflammatory response by myeloperoxidase-oxidized LDL.

Authors:  Karim Zouaoui Boudjeltia; Ilham Legssyer; Pierre Van Antwerpen; Roger Lema Kisoka; Sajida Babar; Nicole Moguilevsky; Paul Delree; Jean Ducobu; Claude Remacle; Michel Vanhaeverbeek; Dany Brohee
Journal:  Biochem Cell Biol       Date:  2006-10       Impact factor: 3.626

8.  Simultaneous measurement of protein-bound 3-chlorotyrosine and homocitrulline by LC-MS/MS after hydrolysis assisted by microwave: application to the study of myeloperoxidase activity during hemodialysis.

Authors:  Cédric Delporte; Thierry Franck; Caroline Noyon; Damien Dufour; Alexandre Rousseau; Philippe Madhoun; Jean-Marc Desmet; Didier Serteyn; Martine Raes; Joëlle Nortier; Michel Vanhaeverbeek; Nicole Moguilevsky; Jean Nève; Luc Vanhamme; Pierre Van Antwerpen; Karim Zouaoui Boudjeltia
Journal:  Talanta       Date:  2012-06-26       Impact factor: 6.057

9.  Monoclonal antibodies against LDL progressively oxidized by myeloperoxidase react with ApoB-100 protein moiety and human atherosclerotic lesions.

Authors:  N Moguilevsky; K Zouaoui Boudjeltia; S Babar; P Delrée; I Legssyer; Y Carpentier; M Vanhaeverbeek; J Ducobu
Journal:  Biochem Biophys Res Commun       Date:  2004-10-29       Impact factor: 3.575

10.  Soluble RAGE blocks scavenger receptor CD36-mediated uptake of hypochlorite-modified low-density lipoprotein.

Authors:  Gunther Marsche; Bernd Weigle; Wolfgang Sattler; Ernst Malle
Journal:  FASEB J       Date:  2007-05-29       Impact factor: 5.191

View more
  25 in total

Review 1.  Lipoproteins and fatty acids in chronic kidney disease: molecular and metabolic alterations.

Authors:  Heidi Noels; Michael Lehrke; Raymond Vanholder; Joachim Jankowski
Journal:  Nat Rev Nephrol       Date:  2021-05-10       Impact factor: 28.314

Review 2.  Neutrophils as regulators of cardiovascular inflammation.

Authors:  Carlos Silvestre-Roig; Quinte Braster; Almudena Ortega-Gomez; Oliver Soehnlein
Journal:  Nat Rev Cardiol       Date:  2020-01-29       Impact factor: 32.419

3.  Preparation of LDL , Oxidation , Methods of Detection, and Applications in Atherosclerosis Research.

Authors:  Chandrakala Aluganti Narasimhulu; Sampath Parthasarathy
Journal:  Methods Mol Biol       Date:  2022

Review 4.  Unexpected Role of MPO-Oxidized LDLs in Atherosclerosis: In between Inflammation and Its Resolution.

Authors:  Cecilia Tangeten; Karim Zouaoui Boudjeltia; Cedric Delporte; Pierre Van Antwerpen; Keziah Korpak
Journal:  Antioxidants (Basel)       Date:  2022-04-28

5.  Transiently produced hypochlorite is responsible for the irreversible inhibition of chlorite dismutase.

Authors:  Stefan Hofbauer; Clemens Gruber; Katharina F Pirker; Axel Sündermann; Irene Schaffner; Christa Jakopitsch; Chris Oostenbrink; Paul G Furtmüller; Christian Obinger
Journal:  Biochemistry       Date:  2014-05-06       Impact factor: 3.162

Review 6.  Blood flow modulation of vascular dynamics.

Authors:  Juhyun Lee; René R Sevag Packard; Tzung K Hsiai
Journal:  Curr Opin Lipidol       Date:  2015-10       Impact factor: 4.776

7.  Triazolopyrimidines identified as reversible myeloperoxidase inhibitors.

Authors:  Franck Duclos; Lynn M Abell; David G Harden; Kristen Pike; Kimberly Nowak; Gregory A Locke; Gerald J Duke; Xiaoqin Liu; Gayani Fernando; Scott A Shaw; Benjamin P Vokits; Nicholas R Wurtz; Andrew Viet; Meriah N Valente; Sylwia Stachura; Paul Sleph; Javed A Khan; Ji Gao; Ashok R Dongre; Lei Zhao; Ruth R Wexler; David A Gordon; Ellen K Kick
Journal:  Medchemcomm       Date:  2017-10-26       Impact factor: 3.597

8.  Multidomain human peroxidasin 1 is a highly glycosylated and stable homotrimeric high spin ferric peroxidase.

Authors:  Monika Soudi; Martina Paumann-Page; Cedric Delporte; Katharina F Pirker; Marzia Bellei; Eva Edenhofer; Gerhard Stadlmayr; Gianantonio Battistuzzi; Karim Zouaoui Boudjeltia; Paul G Furtmüller; Pierre Van Antwerpen; Christian Obinger
Journal:  J Biol Chem       Date:  2015-02-24       Impact factor: 5.157

9.  Oxidized Lipids and Lipoprotein Dysfunction in Psoriasis.

Authors:  Alexander V Sorokin; Alan T Remaley; Nehal N Mehta
Journal:  J Psoriasis Psoriatic Arthritis       Date:  2020-08-26

Review 10.  Modified low density lipoprotein and lipoprotein-containing circulating immune complexes as diagnostic and prognostic biomarkers of atherosclerosis and type 1 diabetes macrovascular disease.

Authors:  Alexander N Orekhov; Yuri V Bobryshev; Igor A Sobenin; Alexandra A Melnichenko; Dimitry A Chistiakov
Journal:  Int J Mol Sci       Date:  2014-07-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.